| BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas S Beà, F Tort, M Pinyol, X Puig, L Hernández, S Hernández, ... Cancer research 61 (6), 2409-2412, 2001 | 669 | 2001 |
| Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction S Bea, A Zettl, G Wright, I Salaverria, P Jehn, V Moreno, C Burek, G Ott, ... Blood 106 (9), 3183-3190, 2005 | 533 | 2005 |
| Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features A Navarro, G Clot, C Royo, P Jares, A Hadzidimitriou, A Agathangelidis, ... Cancer research 72 (20), 5307-5316, 2012 | 283 | 2012 |
| Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas S Beà, L Colomo, A López-Guillermo, I Salaverria, X Puig, M Pinyol, ... Journal of Clinical Oncology 22 (17), 3498-3506, 2004 | 144 | 2004 |
| Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome) S Beà, A López-Guillermo, M Ribas, X Puig, M Pinyol, A Carrió, L Zamora, ... The American journal of pathology 161 (3), 957-968, 2002 | 137 | 2002 |
| Clinicopathological and molecular characterization of colorectal micropapillary carcinoma M Verdu, R Román, M Calvo, N Rodon, B García, M González, A Vidal, ... Modern Pathology 24 (5), 729-738, 2011 | 104 | 2011 |
| CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas F Tort, S Hernandez, S Bea, A Martınez, M Esteller, JG Herman, X Puig, ... Blood, The Journal of the American Society of Hematology 100 (13), 4602-4608, 2002 | 97 | 2002 |
| Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial B Revollo, I Blanco, P Soler, J Toro, N Izquierdo-Useros, J Puig, X Puig, ... The Lancet Infectious Diseases 21 (10), 1365-1372, 2021 | 85 | 2021 |
| MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas A Navarro, S Bea, V Fernández, M Prieto, I Salaverria, P Jares, ... Cancer research 69 (17), 7071-7078, 2009 | 85 | 2009 |
| Urgencias médicas. Análisis de 18.240 pacientes atendidos en el servicio de urgencias de un hospital general en el periodo de un año J Lloret, X Puig, J Muñoz Med Clin (Barc) 83 (4), 135-141, 1984 | 68 | 1984 |
| Mercado de renta variable y mercado de divisas: Las bolsas de valores: mercados de rentas variables y de divisas y las formas de analizarlo X Brun, OE Benito, O Elvira, X Puig Profit Editorial, 2008 | 67 | 2008 |
| The changing relationship between tax and financial reporting in Spain E Oliveras And, X Puig Accounting in Europe 2 (1), 195-207, 2005 | 58 | 2005 |
| The impact of avoidable mortality on life expectancy at birth in Spain: changes between three periods, from 1987 to 2001 R Gispert, I Serra, MA Bares, X Puig, A Puigdefabregas, A Freitas Journal of Epidemiology & Community Health 62 (9), 783-789, 2008 | 57 | 2008 |
| Matemática financiera y estadística básica: cálculos financieros y conocimientos estadísticos básicos X Brun, OE Benito, O Elvira, X Puig Profit Editorial, 2008 | 50 | 2008 |
| Genetic and immunophenotype analyses of TP53 in bladder cancer: TP53 alterations are associated with tumor progression N Erill, A Colomer, M Verdú, R Román, E Condom, N Hannaoui, ... Diagnostic Molecular Pathology 13 (4), 217-223, 2004 | 50 | 2004 |
| Revisión y aportación de datos sobre quirópteros de Catalunya: Propuesta de Lista Roja C Flaquer, X Puig, E Fàbregas, D Guixé, I Torre, RG Ràfols, F Páramo, ... Galemys 22 (1), 29-61, 2010 | 43 | 2010 |
| Càncer Catalunya 2001 JM Borràs, J Borràs, FX Bosch, E Fernández, J Galceran, R Gispert, ... L'Hospitalet: Institut Català d'Oncologia, Departament de Sanitat i …, 2001 | 41 | 2001 |
| Analysis of Aurora‐A and hMPS1 mitotic kinases in mantle cell lymphoma E Camacho, S Bea, I Salaverría, A López‐Guillermo, X Puig, Y Benavente, ... International journal of cancer 118 (2), 357-363, 2006 | 38 | 2006 |
| Lack of p53 nuclear immunostaining is not indicative of absence of TP53 gene mutations in colorectal adenocarcinomas A Colomer, N Erill, M Verdú, R Roman, A Vidal, C Cordon-Cardo, X Puig Applied Immunohistochemistry & Molecular Morphology 11 (2), 130-137, 2003 | 36 | 2003 |
| Análisis técnico bursátil O Elvira, X Puig BARCELONA: GESTION 2000,, 2001 | 35 | 2001 |
